Assets

Developing a Customizable Complement-Dependent Cytotoxicity Assay

Written by Svar Life Science | May 3, 2024 6:45:00 AM

In this Editorial Article, cell-engineering experts and bioassay experts at Svar Life Science delve into the nuances of developing a CDC assay that goes beyond pure interaction and truly reflects cell lysis

The article also presents how this advanced engineering platform works and how it enables the design and construction of complex and sophisticated components. The possibilities regarding the potential number of target combinations are endless!